avv2.bsky.social
👤 Joined on 02 February 2025
Followers
Following
Total Posts
@avv2.bsky.socialMarch Biosciences has dosed its first patient in a phase 2 trial evaluating its first-in-class CD5-targeted CAR-T cell therapy for patients with relapsed or refractory CD5-positive T-cell lymphoma. 🧪🧬⑂ #CellTherapy #SciComm
Show PostRepublicans aren’t hiding anything. Their priorities are written in black and white: trillions of dollars in tax breaks to the rich, while making savage cuts to Medicaid, housing, nutrition and education. The reconciliation bill will make the rich even richer and the poor poorer.
Show PostThis is what “do something” looks like
Show PostRALLY FROM THE TREASURY BUILDING: We are here to tell Elon Musk and DOGE that a secret squad of company men cannot pull off a hostile takeover of America's Social Security and tax information in the dead of night. youtu.be/G4vt0uvXbp4
Show Post